Journal article
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis
S Bazzocco, H Dopeso, Á Martínez-Barriocanal, E Anguita, R Nieto, J Li, E García-Vidal, V Maggio, P Rodrigues, PG de Marcondes, S Schwartz, LA Aaltonen, A Sánchez, JM Mariadason, D Arango
Clinical Epigenetics | BMC | Published : 2021
Abstract
Background: Cancer initiation and progression are driven by genetic and epigenetic changes. Although genome/exome sequencing has significantly contributed to the characterization of the genetic driver alterations, further investigation is required to systematically identify cancer driver genes regulated by promoter hypermethylation. Results: Using genome-wide analysis of promoter methylation in 45 colorectal cancer cell lines, we found that higher overall methylation levels were associated with microsatellite instability (MSI), faster proliferation and absence of APC mutations. Because epigenetically silenced genes could represent important oncogenic drivers, we used mRNA expression profilin..
View full abstractGrants
Awarded by Agència de Gestió d'Ajuts Universitaris i de Recerca
Funding Acknowledgements
This study was partially funded by grants of the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF; PI16/00540, PI19/00993, AC20/00022 and AC15/00066) and the Spanish Association Against Cancer (AECC GCA15152966ARAN) to Diego Arango.